Bacteria differentially induce degradation of Bcl-xL, a survival protein, by human platelets

Blood

Volumn 120, Issue 25, 2012, Pages 5014-5020

  Kraemer, Bjoern F ^a,b,c   Campbell, Robert A ^a   Schwertz, Hansjörg ^a   Franks, Zechariah G ^a   De Abreu, Adriana Vieira ^a,d   Grundler, Katharina ^c   Kile, Benjamin T ^e,f   Dhakal, Bijaya K ^a   Rondina, Matthew T ^a   Kahr, Walter H A ^g   Mulvey, Matthew A ^a   Blaylock, Robert C ^a,h   Zimmerman, Guy A ^a   Weyrich, Andrew S ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Institut fuer Pathologie   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g UNIVERSITY OF TORONTO   (Canada)

^h ARUP LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALPHA HEMOLYSIN; CALPAIN; PROTEIN BCL XL; REGULATOR PROTEIN;

APOPTOSIS; ARTICLE; BACTERIAL METABOLISM; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CONTROLLED STUDY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SEPSIS; STAPHYLOCOCCUS AUREUS; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTOPENIA;

EID: 84871043440     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-04-420661     Document Type: Article

References (49)

1. Shorr AF, Tabak YP, Killian AD, Gupta V, Liu LZ, Kollef MH. Healthcare-associated bloodstream infection: a distinct entity? Insights from a large U.S. database. Crit Care Med. 2006;34(10):2588-2595. (Pubitemid 44413057)
2. de Kraker ME, Davey PG, Grundmann H. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med. 2011;8(10):e1001104.
3. Weber DJ, Rutala WA. Central line-associated bloodstream infections: prevention and management. Infect Dis Clin North Am. 2011;25(1):77-102.
4. Niven DJ, Fick GH, Kirkpatrick AW, Grant V, Laupland KB. Cost and outcomes of nosocomial bloodstream infections complicating major traumatic injury. J Hosp Infect. 2010;76(4):296-299.
5. Petti CA, Sanders LL, Trivette SL, Briggs J, Sexton DJ. Postoperative bacteremia secondary to surgical site infection. Clin Infect Dis. 2002;34(3):305-308. (Pubitemid 34062229)
6. Chen CY, Tsay W, Tang JL, et al. Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia. Epidemiol Infect. 2010;138(7):1044-1051.
7. Chrissoheris MP, Libertin C, Ali RG, Ghantous A, Bekui A, Donohue T. Endocarditis complicating central venous catheter bloodstream infections: a unique form of health care associated endocarditis. Clin Cardiol. 2009;32(12):E48-E54.
8. Al-Hasan MN, Eckel-Passow JE, Baddour LM. Bacteremia complicating gram-negative urinary tract infections: a population-based study. J Infect. 2010;60(4):278-285.
9. Harris E, Rondina MT, Schwertz H, Weyrich AS. Pathogenesis of sepsis and sepsis-induced acute lung injury. In: Choi AMK, ed. Acute Respiratory Distress Syndrome. New York, NY: Informa Healthcare; 2010:369-419.
10. Vandijck DM, Blot SI, De Waele JJ, Hoste EA, Vandewoude KH, Decruyenaere JM. Thrombocytopenia and outcome in critically ill patients with bloodstream infection. Heart Lung. 2010;39(1):21-26.
11. Gafter-Gvili A, Mansur N, Bivas A, et al. Thrombocytopenia in Staphylococcus aureus bacteremia: risk factors and prognostic importance. Mayo Clin Proc. 2011;86(5):389-396.
12. Bozza FA, Shah AM,Weyrich AS, Zimmerman GA. Amicus or adversary: platelets in lung biology, acute injury, and inflammation. Am J Respir Cell Mol Biol. 2009;40(2):123-134.
13. Cox D, Kerrigan SW, Watson SP. Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation. J Thromb Haemost. 2011;9(6):1097-1107.
14. Mason KD, Carpinelli MR, Fletcher JI, et al. Programmed anuclear cell death delimits platelet life span. Cell. 2007;128(6):1173-1186. (Pubitemid 46427871)
15. Josefsson EC, James C, Henley KJ, et al. Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce platelets. J Exp Med. 2011;208(10):2017-2031.
16. Dasgupta SK, Argaiz ER, Mercado JE, et al. Platelet senescence and phosphatidylserine exposure. Transfusion. 2010;50(10):2167-2175.
17. Roberts AW, Seymour JF, Brown JR, et al. Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease. J Clin Oncol. 2012;30(5):488-496.
18. Schoenwaelder SM, Jarman KE, Gardiner EE, et al. Bcl-xL-inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets. Blood. 2011;118(6):1663-1674.
19. Vogler M, Hamali HA, Sun XM, et al. BCL2/BCL-X(L) inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation. Blood. 2011;117(26):7145-7154.
20. Wilson WH, O'Connor OA, Czuczman MS, et al. Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity. Lancet Oncol. 2010;11(12):1149-1159.
21. Zhang H, Nimmer PM, Tahir SK, et al. Bcl-2 family proteins are essential for platelet survival. Cell Death Differ. 2007;14(5):943-951. (Pubitemid 46655455)
22. Kodama T, Takehara T, Hikita H, et al. BH3-only activator proteins Bid and Bim are dispensable for Bak/Bax-dependent thrombocyte apoptosis induced by Bcl-xL deficiency: molecular requisites for the mitochondrial pathway to apoptosis in platelets. J Biol Chem. 2011;286(16):13905-13913.
23. Schoenwaelder SM, Yuan Y, Josefsson EC, et al. Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function. Blood. 2009;114(3):663-666.
24. Dowling MR, Josefsson EC, Henley KJ, Hodgkin PD, Kile BT. Platelet senescence is regulated by an internal timer, not damage inflicted by hits. Blood. 2010;116(10):1776-1778.
25. Kraemer BF, Campbell RA, Schwertz H, et al. Novel anti-bacterial activities of beta-defensin 1 in human platelets: suppression of pathogen growth and signaling of neutrophil extracellular trap formation. PLoS Pathog. 2011;7(11):e1002355.
26. Mulvey MA, Schilling JD, Hultgren SJ. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun. 2001;69(7):4572-4579. (Pubitemid 32574459)
27. Wiles TJ, Dhakal BK, Eto DS, Mulvey MA. Inactivation of host Akt/protein kinase B signaling by bacterial pore-forming toxins. Mol Biol Cell. 2008;19(4):1427-1438. (Pubitemid 351805097)
28. Bauer ME, Welch RA. Characterization of an RTX toxin from enterohemorrhagic Escherichia coli O157:H7. Infect Immun. 1996;64(1):167-175.
29. Lee DH, Goldberg AL. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 1998;8(10):397-403. (Pubitemid 28458705)
30. White MJ, Schoenwaelder SM, Josefsson EC, et al. Caspase-9 mediates the apoptotic death of megakaryocytes and platelets, but is dispensable for their generation and function. Blood. 2012;119(18):4283-4290.
31. Schindel C, Zitzer A, Schulte B, et al. Interaction of Escherichia coli hemolysin with biological membranes. A study using cysteine scanning mutagenesis. Eur J Biochem. 2001;268(3):800-808. (Pubitemid 32862640)
32. Bhakdi S, Mackman N, Menestrina G, et al. The hemolysin of Escherichia coli. Eur J Epidemiol. 1988;4(2):135-143.
33. Schubert S, Schwertz H, Weyrich AS, et al. Staphylococcus aureus alpha-Toxin triggers the synthesis of B-cell lymphoma 3 by human platelets. Toxins (Basel). 2011;3(2):120-133.
34. Gagliotti C, Balode A, Baquero F, et al. Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009. Euro Surveill. 2011;16(11):pii: 19819.
35. Rondina MT, Schwertz H, Harris ES, et al. The septic milieu triggers expression of spliced tissue factor mRNA in human platelets. J Thromb Haemost. 2011;9(4):748-758.
36. Gil-Parrado S, Fernandez-Montalvan A, Assfalg-Machleidt I, et al. Ionomycin-activated calpain triggers apoptosis. A probable role for Bcl-2 family members. J Biol Chem. 2002;277(30):27217-27226. (Pubitemid 34951738)
37. Park K, Lee JH. Bcl-XL protein is markedly decreased in UVB-irradiated basal cell carcinoma cell lines through proteasome-mediated degradation. Oncol Rep. 2009;21(3):689-692.
38. Opal SM, Cross AS, Gemski P, Lyhte LW. Aerobactin and alpha-hemolysin as virulence determinants in Escherichia coli isolated from human blood, urine, and stool. J Infect Dis. 1990;161(4):794-796. (Pubitemid 20120244)
39. Bhakdi S, Muhly M, Korom S, Schmidt G. Effects of Escherichia coli hemolysin on human monocytes. Cytocidal action and stimulation of interleukin 1 release. J Clin Invest. 1990;85(6):1746-1753. (Pubitemid 20192945)
40. Russo TA, Davidson BA, Genagon SA, et al. E. coli virulence factor hemolysin induces neutrophil apoptosis and necrosis/lysis in vitro and necrosis/lysis and lung injury in a rat pneumonia model. Am J Physiol Lung Cell Mol Physiol. 2005;289(2):L207-216. (Pubitemid 41008902)
41. Suttorp N, Floer B, Schnittler H, Seeger W, Bhakdi S. Effects of Escherichia coli hemolysin on endothelial cell function. Infect Immun. 1990;58(11):3796-3801. (Pubitemid 20353385)
42. Dhakal BK, Mulvey MA. The UPEC pore-forming toxin alpha-hemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory, and survival pathways. Cell Host Microbe. 2012;11(1):58-69.
43. Koschinski A, Repp H, Unver B, et al. Why Escherichia coli alpha-hemolysin induces calcium oscillations in mammalian cells - the pore is on its own. FASEB J. 2006;20(7):973-975.
44. Uhlen P, Laestadius A, Jahnukainen T, et al. Alpha-haemolysin of uropathogenic E. coli induces Ca2+ oscillations in renal epithelial cells. Nature. 2000;405(6787):694-697. (Pubitemid 30428656)
45. Zhang W, Liu J, Sun R, et al. Calpain activator dibucaine induces platelet apoptosis. Int J Mol Sci. 2011;12(4):2125-2137.
46. Bhakdi S, Tranum-Jensen J. Alpha-toxin of Staphylococcus aureus. Microbiol Rev. 1991; 55(4):733-751. (Pubitemid 21895174)
47. Bhakdi S, Muhly M, Mannhardt U, et al. Staphylococcal alpha toxin promotes blood coagulation via attack on human platelets. J Exp Med. 1988;168(2):527-542.
48. Pollock WK, Rink TJ. Thrombin and ionomycin can raise platelet cytosolic Ca2+ to micromolar levels by discharge of internal Ca2+ stores: studies using fura-2. Biochem Biophys Res Commun. 1986;139(1):308-314. (Pubitemid 16007277)
49. Sy RW, Chawantanpipat C, Richmond DR, Kritharides L. Thrombocytopenia and mortality in infective endocarditis. J Am Coll Cardiol. 2008;51(18):1824-1825. (Pubitemid 351608492)